SkinHealth Systems Inc 8-K/A, filed Jun 29, 2022
SkinHealth Systems Inc. (SKIN)
8-K/A
2022-06-29
For: 2022-06-06
View Original
Added on
April 10, 2026
About this 8-K/A
SkinHealth Systems Inc filed this 8-K/A on June 29, 2022, reporting on events of June 6, 2022.
Items reported
- Item 5.02: Director or officer change, or executive pay
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 6, 2022
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
(Address of principal executive offices)
(Zip Code)
(800 ) 603-4996
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
The | ||||||||||||||
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory Note
This Amendment No. 1 on Form 8-K/A amends Item 5.02 of the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 6, 2022 (the “Original Filing”) by The Beauty Health Company (the “Company”). The Original Filing reported, among other items, the appointment of Ms. Marla Beck to the Company’s Board of Directors (the “Board”). At the time of the Original Filing, the Board had not made any determination regarding a committee assignment for Ms. Beck.
The Company hereby amends the Original Filing to include information on Ms. Beck’s committee assignment in Item 5.02 below.
Other than providing the additional information in Item 5.02 below, no other disclosure in the Original Filing is amended by this Form 8-K/A.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 28, 2022, the Board appointed Ms. Beck to serve as a member of the Company’s Audit Committee, effective immediately. The Board has determined that Ms. Beck is independent.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: June 29, 2022 | The Beauty Health Company | |||||||
| By: | /s/ Liyuan Woo | |||||||
| Name: | Liyuan Woo | |||||||
| Title: | Chief Financial Officer | |||||||